Iovance Biotherapeutics Inc (NAS:IOVA)
$ 8.88 -0.115 (-1.28%) Market Cap: 2.48 Bil Enterprise Value: 2.21 Bil PE Ratio: 0 PB Ratio: 3.65 GF Score: 39/100

Iovance Biotherapeutics Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 03, 2020 / 05:00PM GMT
Release Date Price: $32.17 (-3.45%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Good afternoon, everyone. This is Biren Amin, biotech analyst here at Jefferies. I'd like to welcome everyone to the Jefferies Healthcare Conference, I'd like to introduce our next company. We have high Iovance Biotherapeutics and their CEO, Maria Fardis; as well as CFO, Tim Morris.

This is going to be a fireside chat format. So if anyone wishes to ask management a question, you can feel free to e-mail me [email protected].

Questions & Answers

Biren N. Amin;Maria Fardis
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst;Iovance

So thanks, Maria, for joining us this afternoon or morning to you, I guess. Maybe just if you could go over just top line, in terms of updates in the melanoma and cervical program, just the time lines around those product programs and when we can expect data from Cohort 4 in terms of the IRC review data as well as cervical and when we can expect data from that cohort.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot